查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095083

皮膚科準分子雷射市場：全球市場預測（2026-2032 年）

Dermatology Excimer Laser Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，皮膚科準分子雷射市場將成長至 13.976 億美元，複合年成長率為 14.13%。

主要市場統計數據
基準年（2025 年） 5.5409億美元
預計年份（2026年） 6.2632億美元
預測年份（2032年） 13.976億美元
複合年成長率（） 14.13%

皮膚科準分子雷射市場簡介

皮膚科準分子雷射技術是一種標靶照光治療，主要用於治療發炎性和色素性皮膚疾病。 308奈米準分子雷射波長廣泛應用於臨床皮膚科，用於治療局限性脫髮症、白斑症、異位性皮膚炎、斑禿以及某些類型的白化病。與全身照光治療不同，準分子雷射系統可將高濃度的紫外線B（UVB）能量集中輸送到患處，同時限制周圍健康皮膚的暴露。這使得治療更加精準，治療時間更短，並且能夠適應解剖學上定義的斑塊和病變。市場需求受到以下因素的影響：慢性皮膚病臨床負擔日益加重、患者越來越傾向於非系統性療法、門診皮膚科服務的擴展，以及醫生對能夠補充外用藥物、生物製藥和傳統照光治療的基於設備的治療方案的持續關注。該領域也受到更嚴格的安全要求、保險報銷差異、培訓要求以及記錄不同膚質臨床療效的需求等因素的影響。隨著皮膚科實踐中擴大採用個體化護理模式，準分子雷射系統因其易用性、劑量控制、治療部位適應性、維護可靠性、患者處理能力以及與循證護理路徑的整合等優點而日益受到重視。

皮膚科準分子雷射領域的變革性變化

皮膚科準分子雷射領域的發展正從以設備為中心的應用轉向以治療效果為優先的、基於治療方案的治療模式。診所優先考慮能夠提供穩定劑量、針對特定病灶制定治療方案、符合人體工學設計的牙科手機以及簡化工作流程的系統，以滿足高頻門診使用的需求。聯合治療的日益普及也在改變臨床實踐；根據疾病嚴重程度和患者情況，準分子雷射治療通常會與外用皮質類固醇、Calcineurin酶抑制劑、維生素D類似物、全身療法和生物製藥合併使用。患者的期望也在發生變化，他們更加重視可見的療效、減輕治療負擔以及最大限度地減少全身副作用。同時，醫療專業人員也越來越關注皮膚光型、累積紫外線照射量、禁忌症以及治療後後續觀察。對能量型醫療設備的監管、對從業人員的訓練要求以及對安全操作規程的記錄，都要求製造商和醫療機構提供更高水準的品管。此外，皮膚病學領域的數位化進步，如影像記錄、電子治療記錄、遠端皮膚病學後續觀察以及數據驅動的藥物依從性監測，也正在極大地改變該領域的格局。

人工智慧在準分子雷射皮膚病治療的累積影響。

人工智慧 (AI) 正在逐步影響皮膚科準分子雷射治療的工作流程，其作用並非取代醫生主導的治療決策，而是透過改進評估、個人化治療和長期監測來實現。 AI 驅動的皮膚影像技術可以輔助病灶分割、嚴重程度評分和長期視覺對比，這對於白斑症和局部乾癬等疾病尤其重要，因為這些疾病的治療反應模式可能因身體部位和皮膚類型而異。機器學習工具與臨床記錄系統整合，有助於整理治療史、劑量反應、漏診記錄、不利事件和照片記錄，從而實現更一致的隨訪和可審計的護理。 AI 還有助於提高營運效率，例如幫助識別可能受益於靶向照光治療的患者群體、最佳化預約安排以及在適用情況下規範記錄以支持保險報銷。然而，在皮膚科準分子雷射治療中使用 AI 需要嚴格的監管，包括檢驗不同膚色人群的治療效果、醫生監督、網路安全措施、透明的數據處理以及管治醫療設備和健康數據相關法規。因此，人工智慧的累積影響最好被理解為“基礎層”，它提高了準分子雷射治療程序的準確性、一致性和記錄保存能力。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區皮膚病患者數量龐大，私人醫療基礎設施不斷完善，人們對白斑症、乾癬和美容皮膚科治療的認知度日益提高。中國、印度、日本、韓國和澳洲透過各自的醫療模式和報銷機制，推動了這項需求的成長。在北美，先進的皮膚科醫療設備應用已較為成熟，這得益於專業診所網路、對相關治療程序的高度認知以及標靶照光治療的成熟臨床應用。然而，保險公司的承保範圍和文件要求正在影響其應用。在拉丁美洲，隨著巴西和墨西哥私立皮膚科服務及醫療美容基礎設施的擴展，相關醫療器材的應用也逐漸進行。同時，成本效益、培訓機會和設備資金籌措仍然是重要的考量。歐洲受益於強大的皮膚病學研究網路、系統的法律規範以及廣泛的照光治療臨床知識，準分子雷射的應用受到各國醫療報銷政策和公私合營醫療體系的影響。在中東，推動這一趨勢的因素包括對專科醫療保健的投資、部分國家對醫療旅遊的高度重視，以及針對不同膚質的色素沉著和炎症性皮膚病的皮膚科服務需求的不斷成長。非洲對於準分子雷射的應用仍是一個新興市場，其部署主要集中在都市區私立醫療機構，並受到專家數量、設備成本、基礎設施建設以及公共衛生優先事項等因素的影響。

對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團進行分析

東協市場受到私人皮膚科診所和都市區美容醫學中心擴張以及人們對色素沉著和炎症性疾病標靶治療日益成長的認知的影響，但其普及程度因醫療成本、專科醫生密度和進口途徑的不同而存在顯著差異。海灣合作理事會（GCC）國家受益於先進的醫院基礎設施、對專科醫療保健的投資以及對皮膚科服務的強勁需求，使得使用高品質設備進行治療更加便捷，尤其是在都市區。在歐盟，統一的醫療設備法規、嚴格的病人安全標準以及各國報銷制度的差異塑造了市場格局，臨床證據、文件記錄和合規性是推廣應用的關鍵。在金磚國家，大規模的病患群體和多樣化的醫療保健服務為高階都市區診所和醫療機構內的皮膚科都創造了機會。同時，採購模式、當地法規和價格負擔能力也影響產品的普及。在七國集團（G7）國家，在臨床指南、訓練有素的醫護人員和先進的醫療基礎設施的支持下，人們對靶向照光治療的認知度普遍較高，皮膚科醫療設備已深度融入到專科診療實踐中。北約成員國的醫療保健系統成熟度參差不齊，有的成熟，有的正在發展中，實施的可行性取決於每個國家的報銷政策、監管一致性以及接受過雷射和照光治療方案培訓的皮膚科醫生的數量。

主要皮膚科準分子雷射市場各國關鍵洞察

美國憑藉其強大的專科醫生隊伍、完善的門診皮膚科基礎設施以及對該設備治療路徑的深刻理解，仍然是皮膚科準分子雷射應用的主要中心。在加拿大，各省的健保報銷制度和專科醫療服務的可近性影響著準分子雷射的普及。在墨西哥和巴西，不斷擴張的私人皮膚科和美容醫療服務推動了準分子雷射的廣泛應用，而價格承受能力和培訓機會也影響其更廣泛的使用。在英國、德國、法國、義大利和西班牙，準分子雷射的普及與成熟的照光治療實踐、監管合規以及公立和私立醫療保健服務的可及性差異密切相關。同時，俄羅斯的市場動態受到都市區專科醫生集中度和醫療設備可近性的影響。在中國和印度，由於大量人口患有慢性皮膚病和色素性皮膚病，存在著巨大的臨床需求，隨著皮膚科基礎設施的發展，準分子雷射的應用主要集中在都市區醫院和私人專科診所。在日本，精密醫療設備的普及與系統化的臨床實踐之間存在著強烈的相關性。同時，在韓國，先進的皮膚科服務與患者積極參與的護理相結合，重點關注皮膚健康和外觀。在澳大利亞，大都會圈皮膚科醫生的普及以及對紫外線安全性的重視，促進了準分子雷射治療的規範化和謹慎使用。在所有國家，臨床培訓、後續支持、監管合規、患者經濟負擔以及循證治療方案仍然是永續推廣的關鍵因素。

為皮膚科準分子雷射產業的領導者提供實用建議。

產業領導者應優先考慮經臨床驗證的差異化優勢，投資於能夠提高劑量精準度、治療可重複性、操作人員效率和記錄品質的系統。設備開發商和經銷商應透過系統化的培訓項目、針對特定皮膚光型的治療方案、安全檢查清單以及實施後的臨床教育，為皮膚科醫生提供支持，以提高治療的一致性。醫療機構應將準分子雷射治療整合到針對乾癬、白斑症和其他適應症的多學科協作診療路徑中，確保患者選擇得當、提供切合實際的治療結果諮詢以及記錄治療反應。此外，由於停機時間會直接影響診所的運轉率和患者的依從性，各機構應透過提供預防性保養、及時的技術支援以及清晰的耗材和設備所有權成本收費系統來最佳化其服務模式。數位化整合，包括成像、治療記錄、不利事件追蹤以及盡可能與臨床記錄的互通性，應被視為一項競爭優勢。進入新興市場的領導者必須避免採用一刀切的商業化模式，並根據當地的保險報銷條件、培訓資源、進口法規以及患者的經濟承受能力調整策略。在任何環境下，持續成功都取決於透過安全性、實證性、易用性和可衡量的臨床價值來建立信任。

皮膚科準分子雷射分析的調查方法

分析皮膚科準分子雷射的研究途徑應結合二手資料研究、臨床證據審查、監管評估和專家檢驗。可靠的資訊來源包括同行評審的皮膚病學期刊、臨床實踐指南、醫療設備監管資料庫、公共衛生皮膚病學資源、醫院採購文件、報銷政策文件以及關於準分子雷射治療效果的學術論文。應透過與皮膚科醫生、雷射診所營運商、生物醫學工程師、採購負責人、分銷商和醫療保健管理人員進行結構化討論來收集主要見解，以了解實際應用中的障礙和工作流程要求。數據三角驗證對於檢驗臨床證據、監管資訊和醫務人員經驗的研究結果至關重要。這種調查方法應避免推測性估計，而應專注於檢驗的指標，例如已批准的適應症、治療方案、區域使用、報銷趨勢、技術特性、安全注意事項和已記錄的臨床應用歷史。品管應包括核實資訊來源的真實性和及時性，檢驗一致性，以及區分基於證據的結論和基於觀點的說明。

關於皮膚科準分子雷射現況的結論

準分子雷射技術在局部發炎和色素性皮膚病的標靶非系統性治療中佔有重要地位。其價值在於精準的紫外線照射、適用於門診環境以及可整合到個人化皮膚病治療方案中的潛力。該領域正透過改進設備易用性、更完善的安全規程、數位化文件以及對人工智慧驅動的評估和監測日益成長的興趣而不斷進步。區域和全國的普及程度仍然存在差異，受到保險報銷、專家資源、基礎設施、監管要求和患者經濟能力等因素的影響。專注於臨床證據、醫生教育、工作流程整合和可靠售後服務的行業相關人員最有能力推動該技術的長期應用。隨著皮膚病學不斷向個人化、數據驅動和以患者為中心的護理模式轉變，準分子雷射系統將繼續發揮關鍵作用，在靶向照光治療方面提供療效、安全性和便捷性之間的理想平衡。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章 皮膚科準分子雷射市場：依產品類型分類

  • 固定點型
  • 掃描類型

第8章：皮膚科準分子雷射市場：依技術分類

  • 172 nm
  • 222 nm
  • 308 nm

第9章：皮膚科準分子雷射市場：依應用領域分類

  • 脫髮症
  • 異位性皮膚炎
  • 銀屑病
  • 白斑

第10章 皮膚科準分子雷射市場：依最終用戶分類

  • 門診手術中心
  • 皮膚科診所
  • 醫院
  • 研究機構

第11章：皮膚科準分子雷射市場：依分銷管道分類

  • 離線
  • 線上

第12章 皮膚科準分子雷射市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 皮膚科準分子雷射市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 皮膚科準分子雷射市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第16章：公司簡介

  • Aerolase Corporation
  • Bausch Health Companies Inc.
  • Beijing Sincoheren S&T Development Co., Ltd.
  • Candela Corporation
  • Clarteis SAS
  • Cutera, Inc.
  • Cynosure Lutronic, Inc.
  • El.En. SpA
  • Fotona doo
  • GME German Medical Engineering GmbH
  • LAMEDITECH Co., Ltd.
  • LASEROPTEK Co., Ltd.
  • Lumenis Be Ltd.
  • Sciton, Inc.
  • Shanghai SIGMA High-Tech Co., Ltd.
  • Shenzhen GSD Tech Co., Ltd.
  • Sisram Medical Ltd.
  • STRATA Skin Sciences, Inc.
  • The Daavlin Company
  • WONTECH Co., Ltd.
  • Wuhan Qobeauty Tech Co., Ltd.
  • Xuzhou Kernel Medical Equipment Co., Ltd.
Product Code: MRR-563BF1FCF125

The Dermatology Excimer Laser Market is projected to grow by USD 1,397.60 million at a CAGR of 14.13% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 554.09 million
Estimated Year [2026] USD 626.32 million
Forecast Year [2032] USD 1,397.60 million
CAGR (%) 14.13%

Dermatology Excimer Laser Market Introduction

Dermatology excimer laser technology is a targeted phototherapy modality used primarily for inflammatory and pigmentary skin disorders, with the 308 nm excimer wavelength widely applied in clinical dermatology for localized psoriasis, vitiligo, atopic dermatitis, alopecia areata, and selected cases of leukoderma. Unlike whole-body phototherapy, excimer laser systems deliver concentrated ultraviolet B energy to affected lesions while limiting exposure to surrounding healthy skin, supporting treatment precision, shorter session times, and suitability for anatomically defined plaques or patches. Demand is shaped by the rising clinical burden of chronic skin disease, growing patient preference for non-systemic therapies, expanding outpatient dermatology services, and continuing physician interest in device-based treatment options that can complement topical agents, biologics, and conventional phototherapy. The sector is also influenced by stricter safety expectations, reimbursement variability, training requirements, and the need for documented clinical outcomes across diverse skin types. As dermatology practices adopt more personalized care models, excimer laser systems are increasingly evaluated on usability, dose control, treatment-area adaptability, maintenance reliability, patient throughput, and integration into evidence-based care pathways.

Transformative Shifts in the Dermatology Excimer Laser Landscape

The dermatology excimer laser landscape is undergoing a shift from device-centric adoption toward outcome-driven, protocol-based treatment delivery. Clinics are prioritizing systems that support consistent dosing, lesion-specific treatment plans, ergonomic handpieces, and simplified workflow for high-frequency outpatient use. The growing use of combination therapy is also reshaping clinical practice, as excimer laser treatment is often considered alongside topical corticosteroids, calcineurin inhibitors, vitamin D analogs, and systemic or biologic therapies depending on disease severity and patient profile. Patient expectations are changing as well, with greater emphasis on visible improvement, reduced treatment burden, and fewer systemic side effects. At the same time, healthcare providers are paying closer attention to skin phototype, cumulative ultraviolet exposure, contraindications, and post-treatment monitoring. Regulatory scrutiny of energy-based medical devices, requirements for operator training, and the need for documented safety protocols are pushing manufacturers and providers toward higher standards of quality management. The landscape is also being transformed by the broader digitalization of dermatology, including image documentation, electronic treatment records, teledermatology-enabled follow-up, and data-supported adherence monitoring.

Cumulative Impact of Artificial Intelligence on Excimer Laser Dermatology

Artificial intelligence is beginning to influence dermatology excimer laser workflows by improving assessment, personalization, and longitudinal monitoring rather than replacing physician-led treatment decisions. AI-assisted dermatology imaging can help support lesion segmentation, severity scoring, and visual comparison over time, which is especially relevant for conditions such as vitiligo and localized psoriasis where response patterns may vary by body site and skin phototype. When integrated with clinical documentation systems, machine learning tools can help organize treatment histories, dose responses, missed sessions, adverse events, and photographic records, enabling more consistent follow-up and audit-ready care. AI can also contribute to operational efficiency by helping clinics identify patient cohorts likely to benefit from targeted phototherapy, optimize appointment scheduling, and standardize documentation for reimbursement support where applicable. However, the use of AI in excimer laser dermatology requires careful governance, including validation across diverse skin tones, physician oversight, cybersecurity safeguards, transparent data handling, and compliance with medical device and health data regulations. The cumulative impact of AI is therefore best understood as an enabling layer that strengthens precision, consistency, and documentation in excimer laser treatment programs.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is characterized by a large dermatology patient base, expanding private healthcare infrastructure, and rising awareness of vitiligo, psoriasis, and cosmetic dermatology treatments, with China, India, Japan, South Korea, and Australia contributing to demand through different care models and reimbursement environments. North America demonstrates mature adoption of advanced dermatology devices, supported by specialist clinic networks, high procedural awareness, and established clinical use of targeted phototherapy, although payer coverage and documentation requirements influence utilization. Latin America is seeing gradual uptake as Brazil and Mexico expand private dermatology services and medical aesthetics infrastructure, while affordability, training access, and equipment financing remain key considerations. Europe benefits from strong dermatology research networks, structured regulatory oversight, and broad clinical familiarity with phototherapy, with excimer laser adoption influenced by national healthcare reimbursement policies and public-private care pathways. The Middle East is supported by investment in specialty healthcare, a high focus on medical tourism in selected countries, and increasing demand for dermatology services that address pigmentary and inflammatory skin conditions across diverse skin types. Africa remains an emerging setting for excimer laser deployment, where adoption is concentrated in urban private centers and is shaped by specialist availability, device cost, infrastructure readiness, and competing public health priorities.

Key Group Insights for ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are influenced by the expansion of private dermatology clinics, urban medical aesthetics centers, and growing awareness of targeted treatments for pigmentary and inflammatory disorders, although adoption varies widely based on healthcare spending, specialist density, and import pathways. GCC countries benefit from advanced hospital infrastructure, investment in specialty care, and strong demand for dermatology services, particularly in urban centers where premium device-based treatments are more accessible. The European Union is shaped by harmonized medical device regulation, robust patient safety standards, and national differences in reimbursement, making clinical evidence, documentation, and compliance central to adoption. BRICS countries combine large patient populations with varied healthcare access, creating opportunities in both premium urban clinics and institutional dermatology departments, while procurement models, local regulation, and affordability influence deployment. G7 markets generally show higher awareness of targeted phototherapy and stronger integration of dermatology devices into specialist practice, supported by clinical guidelines, trained providers, and advanced healthcare infrastructure. NATO countries include a broad mix of mature and developing healthcare systems, where adoption depends on national reimbursement policies, regulatory alignment, and the availability of dermatology specialists trained in laser and phototherapy protocols.

Key Country Insights for Major Dermatology Excimer Laser Markets

The United States remains a key center for dermatology excimer laser use due to its large specialist base, outpatient dermatology infrastructure, and familiarity with device-based treatment pathways, while Canada's adoption is shaped by provincial reimbursement structures and access to specialty care. Mexico and Brazil are supported by expanding private dermatology and aesthetic medicine services, with affordability and training influencing broader utilization. In the United Kingdom, Germany, France, Italy, and Spain, excimer laser adoption is linked to established phototherapy practice, regulatory compliance, and varying public and private care access, while Russia's market dynamics are influenced by urban specialist concentration and device procurement conditions. China and India present significant clinical need due to large populations affected by chronic and pigmentary skin disorders, with adoption concentrated in urban hospitals and private specialty clinics as dermatology infrastructure grows. Japan shows strong alignment with precision medical devices and structured clinical practice, while South Korea combines advanced dermatology services with high patient engagement in skin health and appearance-focused care. Australia benefits from specialist dermatology access in metropolitan areas and attention to ultraviolet safety, supporting careful protocol-based use of excimer laser treatment. Across all countries, clinical training, maintenance support, regulatory compliance, patient affordability, and evidence-based treatment selection remain decisive factors for sustainable adoption.

Actionable Recommendations for Dermatology Excimer Laser Industry Leaders

Industry leaders should prioritize clinically validated differentiation by investing in systems that improve dose accuracy, treatment reproducibility, operator ergonomics, and documentation quality. Device developers and distributors should support dermatologists with structured training programs, skin phototype-specific protocols, safety checklists, and post-installation clinical education to improve treatment consistency. Providers should integrate excimer laser treatment into multidisciplinary care pathways for psoriasis, vitiligo, and other eligible conditions, ensuring appropriate patient selection, realistic outcome counseling, and documented response tracking. Organizations should also strengthen service models by offering preventive maintenance, rapid technical support, and clear consumable or ownership cost structures, as downtime directly affects clinic utilization and patient adherence. Digital integration should be treated as a competitive necessity, including image capture, treatment logs, adverse event tracking, and interoperability with clinical records where feasible. Leaders entering emerging markets should adapt strategies to local reimbursement conditions, training availability, import regulations, and patient affordability, while avoiding one-size-fits-all commercialization models. Across all settings, sustained success depends on building trust through safety, evidence, usability, and measurable clinical value.

Research Methodology for Dermatology Excimer Laser Analysis

The research approach for dermatology excimer laser analysis should combine secondary research, clinical evidence review, regulatory assessment, and expert validation. Reliable sources include peer-reviewed dermatology journals, clinical practice guidelines, medical device regulatory databases, public health dermatology resources, hospital procurement references, reimbursement policy documents, and academic publications on excimer laser treatment outcomes. Primary insights should be gathered through structured discussions with dermatologists, laser clinic operators, biomedical engineers, procurement specialists, distributors, and healthcare administrators to understand real-world adoption barriers and workflow requirements. Data triangulation is essential to validate findings across clinical evidence, regulatory information, and provider experience. The methodology should exclude speculative estimates and instead focus on verifiable indicators such as approved indications, treatment protocols, regional access patterns, reimbursement dynamics, technology attributes, safety considerations, and documented clinical use. Quality control should include source authentication, recency checks, consistency review, and separation of evidence-based conclusions from opinion-based commentary.

Conclusion on the Dermatology Excimer Laser Landscape

Dermatology excimer laser technology occupies an important position in targeted, non-systemic treatment for localized inflammatory and pigmentary skin conditions. Its value is reinforced by precision ultraviolet delivery, compatibility with outpatient care, and potential integration into individualized dermatology treatment plans. The sector is advancing through improved device usability, stronger safety protocols, digital documentation, and growing interest in AI-enabled assessment and monitoring. Regional and country-level adoption remains uneven, shaped by reimbursement, specialist availability, infrastructure, regulatory requirements, and patient affordability. Industry participants that focus on clinical evidence, physician education, workflow integration, and reliable after-sales support are best positioned to strengthen long-term adoption. As dermatology care continues to move toward personalized, data-supported, and patient-centered treatment, excimer laser systems remain relevant where targeted phototherapy offers a practical balance of efficacy, safety, and convenience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Dermatology Excimer Laser Market, by Product Type

  • 7.1. Introduction
  • 7.2. Fixed Spot
  • 7.3. Scanning

8. Dermatology Excimer Laser Market, by Technology

  • 8.1. Introduction
  • 8.2. 172 Nm
  • 8.3. 222 Nm
  • 8.4. 308 Nm

9. Dermatology Excimer Laser Market, by Application

  • 9.1. Introduction
  • 9.2. Alopecia Areata
  • 9.3. Atopic Dermatitis
  • 9.4. Psoriasis
  • 9.5. Vitiligo

10. Dermatology Excimer Laser Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Dermatology Clinics
  • 10.4. Hospitals
  • 10.5. Research Institutes

11. Dermatology Excimer Laser Market, by Distribution

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Dermatology Excimer Laser Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Dermatology Excimer Laser Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Dermatology Excimer Laser Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Aerolase Corporation
  • 16.2. Bausch Health Companies Inc.
  • 16.3. Beijing Sincoheren S&T Development Co., Ltd.
  • 16.4. Candela Corporation
  • 16.5. Clarteis SAS
  • 16.6. Cutera, Inc.
  • 16.7. Cynosure Lutronic, Inc.
  • 16.8. El.En. S.p.A.
  • 16.9. Fotona d.o.o.
  • 16.10. GME German Medical Engineering GmbH
  • 16.11. LAMEDITECH Co., Ltd.
  • 16.12. LASEROPTEK Co., Ltd.
  • 16.13. Lumenis Be Ltd.
  • 16.14. Sciton, Inc.
  • 16.15. Shanghai SIGMA High-Tech Co., Ltd.
  • 16.16. Shenzhen GSD Tech Co., Ltd.
  • 16.17. Sisram Medical Ltd.
  • 16.18. STRATA Skin Sciences, Inc.
  • 16.19. The Daavlin Company
  • 16.20. WONTECH Co., Ltd.
  • 16.21. Wuhan Qobeauty Tech Co., Ltd.
  • 16.22. Xuzhou Kernel Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FIXED SPOT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FIXED SPOT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FIXED SPOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SCANNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SCANNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SCANNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 172 NM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 172 NM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 172 NM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 222 NM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 222 NM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 222 NM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 308 NM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 308 NM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 308 NM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALOPECIA AREATA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALOPECIA AREATA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALOPECIA AREATA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PSORIASIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PSORIASIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VITILIGO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VITILIGO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VITILIGO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DERMATOLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DERMATOLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DERMATOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 97. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 115. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. G7 DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 121. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NATO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 134. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CANADA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 140. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. MEXICO DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 146. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. BRAZIL DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED KINGDOM DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GERMANY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 164. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. FRANCE DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 170. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. RUSSIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 176. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. ITALY DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 182. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. SPAIN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 194. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. INDIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 200. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. JAPAN DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 206. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. AUSTRALIA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 212. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. SOUTH KOREA DERMATOLOGY EXCIMER LASER MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL DERMATOLOGY EXCIMER LASER MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 219. GLOBAL DERMATOLOGY EXCIMER LASER MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025